Submit Deal

ARQULE INC

Summary

ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 2.05 B

Avg. Deal Size£ 2.05 B

Market Context

Senior Management

Sort

arqule inc

HQ - United States

Biotechnology

16 Jan 2020

Investment Date

100%

Stake

£ 2.05 B

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy